Marathon Patent Group (MARA) At $0.38 Forms Bottom; Auburn National Bancorporation Has 2 Sentiment

October 9, 2017 - By Adrian Mccoy

Auburn National Bancorporation, Inc

Marathon Patent Group Inc (MARA) formed multiple bottom with $0.35 target or 9.00% below today’s $0.38 share price. Marathon Patent Group Inc (MARA) has $11.34M valuation. About 164,283 shares traded. Marathon Patent Group Inc (NASDAQ:MARA) has declined 87.73% since October 9, 2016 and is downtrending. It has underperformed by 104.43% the S&P500.

Morgan Dempsey Capital Management Llc holds 0.26% of its portfolio in Auburn National Bancorporation Inc for 19,234 shares. Banc Funds Co Llc owns 107,253 shares or 0.18% of their US portfolio. Moreover, Lincoln National Corp has 0.03% invested in the company for 16,055 shares. The California-based Stevens First Principles Investment Advisors has invested 0.02% in the stock. Kennedy Capital Management Inc., a Missouri-based fund reported 15,562 shares.

About 50 shares traded. Auburn National Bancorporation Inc (AUBN) has risen 26.06% since October 9, 2016 and is uptrending. It has outperformed by 9.36% the S&P500.

Analysts await Marathon Patent Group Inc (NASDAQ:MARA) to report earnings on November, 13. They expect $-0.01 EPS, up 97.62% or $0.41 from last year’s $-0.42 per share. After $-0.09 actual EPS reported by Marathon Patent Group Inc for the previous quarter, Wall Street now forecasts -88.89% EPS growth.

Investors sentiment decreased to 0.78 in Q2 2017. Its down 0.31, from 1.09 in 2017Q1. It fall, as 3 investors sold Marathon Patent Group Inc shares while 6 reduced holdings. 4 funds opened positions while 3 raised stakes. 2.00 million shares or 39.63% less from 3.31 million shares in 2017Q1 were reported. The Germany-based Deutsche Bancorporation Ag has invested 0% in Marathon Patent Group Inc (NASDAQ:MARA). Geode Capital Mngmt Limited Liability Co holds 0% or 44,662 shares in its portfolio. Morgan Stanley stated it has 255,095 shares. Cambridge Investment Research holds 0% or 415,220 shares in its portfolio. Blackrock accumulated 4,257 shares or 0% of the stock. Vanguard Group Incorporated accumulated 164,903 shares. Barclays Public Ltd Liability Com reported 0% in Marathon Patent Group Inc (NASDAQ:MARA). Northern, a Illinois-based fund reported 19,240 shares. Panagora Asset Mngmt Incorporated stated it has 334,126 shares. Citadel Advisors Ltd Co has invested 0% in Marathon Patent Group Inc (NASDAQ:MARA). Tci Wealth Advisors Inc holds 0% of its portfolio in Marathon Patent Group Inc (NASDAQ:MARA) for 9,000 shares. Fortress Inv Group Ltd Liability Company, New York-based fund reported 134,409 shares. Goldman Sachs Group Inc reported 0% stake. Creative Planning holds 0% or 859 shares. Royal Bank & Trust Of Canada owns 722 shares.

Among 5 analysts covering Marathon Patent Group Inc (NASDAQ:MARA), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Marathon Patent Group Inc has $8 highest and $7 lowest target. $7.33’s average target is 1808.85% above currents $0.384 stock price. Marathon Patent Group Inc had 7 analyst reports since August 18, 2015 according to SRatingsIntel. The stock has “Hold” rating by Zacks on Tuesday, September 22. On Wednesday, August 19 the stock rating was downgraded by Zacks to “Hold”. The stock of Marathon Patent Group Inc (NASDAQ:MARA) earned “Hold” rating by Zacks on Tuesday, August 25. The firm has “Outperform” rating by Wells Fargo given on Wednesday, October 7.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Adrian Mccoy




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: